ANIP - ANI PHARMACEUTICALS INC

QQQ $ 452.83 $ 6.97 (1.56 %)

DIA $ 399.31 $ 3.70 (0.94 %)

SPY $ 529.09 $ 6.48 (1.24 %)

TLT $ 92.14 $ 1.24 (1.36 %)

GLD $ 220.89 $ 2.80 (1.28 %)

Previous Close

$ 64.82

Open

$ 66.40

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 64.63 - $ 66.51

52 Week Range

$ 40.55 - $ 70.81

Volume

150,915

Average Volume

Market Cap

1.26B

Beta (5Y Monthly)

$ 0.86

PE Ratio (TTM)

$ 37.11

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-10-2024	03-31-2024	10-Q
2	02-29-2024	12-31-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-09-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	03-09-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-10-2022	03-31-2022	10-Q
10	03-15-2022	12-31-2021	10-K
11	11-01-2021	09-30-2021	10-Q
12	08-06-2021	06-30-2021	10-Q
13	05-07-2021	03-31-2021	10-Q
14	03-11-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	02-27-2020	12-31-2019	10-K
19	11-06-2019	09-30-2019	10-Q
20	08-07-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	02-27-2019	12-31-2018	10-K
23	11-06-2018	09-30-2018	10-Q
24	08-07-2018	06-30-2018	10-Q
25	05-08-2018	03-31-2018	10-Q
26	02-27-2018	12-31-2017	10-K
27	11-02-2017	09-30-2017	10-Q
28	08-03-2017	06-30-2017	10-Q
29	05-04-2017	03-31-2017	10-Q
30	03-02-2017	12-31-2016	10-K
31	11-03-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-05-2016	03-31-2016	10-Q
34	02-23-2016	12-31-2015	10-K
35	11-03-2015	09-30-2015	10-Q
36	08-04-2015	06-30-2015	10-Q
37	05-05-2015	03-31-2015	10-Q
38	02-23-2015	12-31-2014	10-K
39	11-10-2014	09-30-2014	10-Q
40	08-07-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Buy on ANI P...
05/13/2024 15:03:46

HC Wainwright & Co. analyst Oren Livnat maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price targ...

ANI Pharmaceuticals Reiterates FY24 Outloo...
05/10/2024 10:59:28

ANI continues to expect total company adjusted non-GAAP gross margin between 62% and 63% and the Company will continue to tax e...

ANI Pharmaceuticals Q1 Adj $1.21 Beats $1....
05/10/2024 10:55:13

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $...

Evaluating ANI Pharmaceuticals: Insights F...
04/23/2024 18:00:36

Guggenheim Reiterates Buy on ANI Pharmaceu...
04/23/2024 16:55:06

Guggenheim analyst Vamil Divan reiterates ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and maintains $77 price target.

ANI Pharmaceuticals Announces The Launch O...
04/09/2024 10:51:13

U.S. annual sales for Baclofen Oral Suspension total approximately $39 million, according to IQVIA data.

ANI Pharmaceuticals Announces the Launch o...
03/27/2024 10:51:50

ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced the launch of Levofloxacin Oral Solution, a generi...

Capital One Initiates Coverage On ANI Phar...
03/15/2024 12:27:18

Capital One analyst Timothy Chiang initiates coverage on ANI Pharmaceuticals (NASDAQ:ANIP) with a Overweight rating.

Alphabet, Dover And 2 Other Stocks Insider...
03/11/2024 12:10:47

The Nasdaq 100 closed lower by around 1.5% on Friday. Investors, meanwhile, focused on some notable insider trades.

Expert Outlook: ANI Pharmaceuticals Throug...
03/05/2024 18:01:03

Guggenheim Maintains Buy on ANI Pharmaceut...
03/05/2024 17:00:46

Guggenheim analyst Vamil Divan maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price target from $70 t...

HC Wainwright & Co. Maintains Buy on ANI P...
03/04/2024 11:37:18

HC Wainwright & Co. analyst Oren Livnat maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price targ...

Truist Securities Maintains Buy on ANI Pha...
03/01/2024 13:23:15

Truist Securities analyst Gregory Fraser maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price target ...

ANI Pharmaceuticals Forecasts 2024 Adjuste...
02/29/2024 11:57:17

ANI Pharmaceuticals Forecasts 2024 Purifie...
02/29/2024 11:56:01

ANI Pharmaceuticals Forecasts 2024 Revenue...
02/29/2024 11:54:25

ANI Pharmaceuticals Q4 Adjusted EPS $1.00 ...
02/29/2024 11:52:11

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $...

Earnings Scheduled For February 29, 2024
02/29/2024 10:15:24

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

ANI Pharmaceuticals's Earnings Outlook
02/28/2024 18:01:44

Truist Securities Maintains Buy Rating for...
02/16/2024 17:00:14